Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

159 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Active, Not Recruiting

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

NCT05133531

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • The Oncology Institute of Hope & Innovation Whittier, California, United States
  • Centro de Estudos e Pesquisas em Hematologia e Oncologia Santo André, São Paulo, Brazil
  • A Beneficencia Portuguesa de Sao Paulo, BP Mirante São Paulo, Brazil
  • Casa de Saude Santa Marcelina São Paulo, Brazil
View all 68 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors

NCT04434092

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Organizacion Medica de Investigacion (OMI) Ciudad Autonoma Buenos Aires, Argentina
  • *X*CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia Santo André, São Paulo, Brazil
  • Beneficencia Portuguesa de Sao Paulo São Paulo, Brazil
  • Peking Union Medical College Hospital Beijing, China
View all 61 locations
View Trial Details
Active, Not Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104

NCT05476887

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Jiangsu Province Hospital Nanjing, China
  • Chinese Academy of Medical Sciences Peking Union Medical College - Institute of Hematology Blood Diseases Hospital Tianjin, China
  • Henan Cancer Hospital Zhengzhou, China
View Trial Details

Related conditions